Ascom Holding Net Income Applicable To Common Shares Over Time
| ASCN Stock | CHF 5.08 0.04 0.79% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Ascom Holding Performance and Ascom Holding Correlation. Ascom |
Cross Equities Net Income Applicable To Common Shares Analysis
Compare Ascom Holding AG and related stocks such as Santhera Pharmaceuticals, Molecular Partners, and S H L Net Income Applicable To Common Shares Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SANN | (8 M) | (8 M) | (8 M) | (8 M) | (8 M) | 5.9 M | (35.4 M) | (51.5 M) | (54.2 M) | (19 M) | (67.7 M) | (55.5 M) | (71.1 M) | 54.8 M | (42 M) | (37.8 M) | (39.7 M) |
| MOLN | (2.3 M) | (2.3 M) | (2.3 M) | (2.3 M) | (2.3 M) | (149 K) | (18.6 M) | (25.4 M) | (37 M) | (36.3 M) | (62.8 M) | (63.8 M) | 117.9 M | (62 M) | (54 M) | (48.6 M) | (46.2 M) |
| SHLTN | 829 K | 829 K | 829 K | 829 K | 829 K | (15.7 M) | (11.1 M) | 2.4 M | 10.1 M | 5.7 M | 278 K | (14.1 M) | (76 K) | (7.1 M) | (28.1 M) | (25.3 M) | (24 M) |
| DOCM | 7.2 M | 7.2 M | 7.2 M | 7.2 M | 7.2 M | 3.4 M | (12.8 M) | (36.2 M) | (39 M) | (52.4 M) | (135.7 M) | (225.7 M) | (171.1 M) | 82.3 M | (97.3 M) | (87.5 M) | (91.9 M) |
| CLTN | 15.6 M | 15.6 M | 15.6 M | 15.6 M | 15.6 M | 13.3 M | 17.3 M | 19.1 M | 17 M | 20 M | 8.2 M | 31.7 M | 26 M | 11.9 M | 20.5 M | 23.5 M | 20.1 M |
| ADXN | (1.8 M) | (1.8 M) | (1.8 M) | (1.8 M) | (1.8 M) | (4.2 M) | (3.1 M) | (3.3 M) | (1.6 M) | (14.8 M) | (12.9 M) | (15.4 M) | (20.8 M) | (10.6 M) | 7.1 M | 6.4 M | 6.7 M |
| EVE | (21.4 M) | (21.4 M) | (21.4 M) | (21.4 M) | (21.4 M) | (31.9 M) | (36 M) | (39 M) | (29.2 M) | (21.6 M) | (29.9 M) | (41.3 M) | (43.4 M) | (105.2 M) | 1 M | 939.4 K | 986.4 K |
| NWRN | (10.1 M) | (10.1 M) | (10.1 M) | (10.1 M) | (10.1 M) | (22.8 M) | (15.2 M) | (5.3 M) | (15 M) | (20.2 M) | (21 M) | (14.9 M) | (17.5 M) | (16.2 M) | 15.8 M | 18.2 M | 19.1 M |
| VBSN | 15.8 M | 15.8 M | 15.8 M | 15.8 M | 15.8 M | 16.1 M | 16.4 M | 16 M | 14.1 M | 12.2 M | 17.8 M | 6.2 M | 11.2 M | 15.1 M | 20.3 M | 18.3 M | 11.7 M |
Ascom Holding AG and related stocks such as Santhera Pharmaceuticals, Molecular Partners, and S H L Net Income Applicable To Common Shares description
The net income that remains after preferred dividends have been deducted, available to common shareholders.My Equities
My Current Equities and Potential Positions
| Ascom Holding AG | ASCN |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | Zugerstrasse 32, Baar, |
| Exchange | SIX Swiss Exchange |
CHF 5.08
Additional Tools for Ascom Stock Analysis
When running Ascom Holding's price analysis, check to measure Ascom Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascom Holding is operating at the current time. Most of Ascom Holding's value examination focuses on studying past and present price action to predict the probability of Ascom Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascom Holding's price. Additionally, you may evaluate how the addition of Ascom Holding to your portfolios can decrease your overall portfolio volatility.